Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.
In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.
The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.
Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.
NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.
In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.
CNBC reports that 23andMe is piloting a new program to incorporate customers' medical histories and lab tests with their genetic data.
A new analysis finds that more than half the drugs recently introduced in Germany don't give any benefit over the existing standard of care, according to New Scientist.
Mashable writes that rising temperature will lead archaeological samples in Greenland to decay.
In Science this week: genomic analysis of ancient cattle finds complex regional variation, and more.
Greek police have found a body thought to be that of developmental biologist Suzanne Eaton, who went missing during a conference there, Nature News says.
Researchers have sequenced the zebra mussel genome, which they say could give insight into how to control the invasive species, says the Star Tribune.
The Boston Globe reports that increased genetic screening of healthy people can make returning disease risk findings tricky.
In Nature this week: a genome-wide association study of peripheral artery disease among US veterans, and more.
Bloomberg reports that some of genetic testing firm Vitagene's records were exposed online, including ones containing genetic information.
The Wall Street Journal writes that fast-tracked drug approvals are becoming routine.
The California Institute for Regenerative Medicine is running out of funding, according to ScienceInsider.
In Genome Biology this week: methylation and gene expression profiles in schizophrenia, genomic variation and selection in the mustard plant, and more.
An analysis of biology conferences appearing in the Proceedings of the National Academy of Sciences finds that few have codes of conduct.
NPR reports on the slower-than-predicted uptake of newborn genome sequencing.
The World Health Organization has updated its list of essential medicines, Reuters reports.
In PNAS this week: characterization of an alternatively spliced autism-linked gene, horizontal gene transfer in soil bacteria, and more.
A Russian researcher says he plans to edit the genomes of embryos from deaf couples, New Scientist reports.
Sandia National Lab researchers found a vulnerable point in the process scientists use to uncover genetic alterations, Health IT Security says.
An analysis finds that though women make up nearly half of individuals participating in research, they are underrepresented in certain studies, according to Quartz.
A new study finds that a positive lab environment can encourage undergraduates to continue to perform research.
A new analysis suggests non-US citizen STEM PhDs might pass up jobs at US-based startups due to visa concerns.
A UK survey of researchers who identified as LGBT+ and allies uncovered evidence of unwelcoming workplace climates in the physical sciences.
At the Guardian, the University of Edinburgh's Nikolay Ogryzko argues that universities need to better invest in postdocs' careers.